Somatic POLE proofreading domain mutation, immune response and prognosis in colorectal cancer: a retrospective, pooled biomarker study
Background<br/> Precision cancer medicine depends on defining distinct tumour subgroups using biomarkers that may occur at very modest frequencies. One such subgroup comprises patients with exceptionally mutated (ultramutated) cancers caused by mutations that impair DNA polymerase epsilon (POL...
Hlavní autoři: | Domingo, E, Freeman-Mills, L, Rayner, E, Glaire, M, Briggs, S, Koelzer, V, Frangou, E, Dutton, P, Kerr, R, Kerr, D, Tomlinson, I, Church, D, EPICOLON consortium |
---|---|
Médium: | Journal article |
Vydáno: |
Lancet
2016
|
Podobné jednotky
-
POLE proofreading domain mutation defines a subset of immunogenic colorectal cancers with excellent prognosis
Autor: Glaire, MA, a další
Vydáno: (2016) -
POLE proofreading mutation, immune response and prognosis in endometrial cancer
Autor: Van Gool, I, a další
Vydáno: (2015) -
POLE proofreading mutations elicit an anti-tumor immune response in endometrial cancer
Autor: Klenerman, P, a další
Vydáno: (2015) -
Adjuvant treatment for POLE proofreading domain-mutant cancers: sensitivity to radiotherapy, chemotherapy, and nucleoside analogues
Autor: Van Gool, I, a další
Vydáno: (2018) -
A panoply of errors: polymerase proofreading domain mutations in cancer
Autor: Rayner, E, a další
Vydáno: (2016)